Latest News

AI-ECG in Heart Failure: Ready for Clinical Practice?
Written by: Heart Failure Academy
AI-ECG in Heart Failure: Ready for Clinical Practice?
Parallax: Ron Blankstein on the Future of Cardiac CT
Written by: Parallax Episode 160
Parallax: Prof Ron Blankstein on the Future of Cardiac CT
ESC Congress 2026 Hot Line Trials: The Complete Hot Line Trial Guide
Written by: Radcliffe Cardiology
ESC Congress 2026 Hot Line Trials Revealed
Finerenone Approved in EU for HF with LVEF ≥40%
Written by: Heart Failure Academy
Finerenone Approved in EU for HF with LVEF ≥40%
Smartwatch Data Predicts Heart Failure Exacerbations
Written by: CFR Journal
Smartwatch Data Predicts Heart Failure Exacerbations
OPTION-STEMI: Staged Revascularisation for STEMI with HF
Written by: Cardiac Failure Review
OPTION-STEMI: Staged Revascularisation for STEMI with HF
TEER Linked to Better Outcomes in AFMR Patients
Written by: Transcatheter Academy
TEER Linked to Better Outcomes in AFMR Patients
LBBP Superior to BiVP for HF Outcomes in HeartSync-LBBP
Written by: Arrhythmia and Electrophysiology Review
LBBP Superior to BiVP for HF Outcomes in HeartSync-LBBP
Aficamten Superior to Metoprolol in oHCM: MAPLE-HCM
Written by: CFR Journal Radcliffe Cardiology
Aficamten Superior to Metoprolol in oHCM: MAPLE-HCM
AI-ECG Enhances Heart Failure Risk Prediction
Written by: Arrhythmia Academy
AI-ECG Enhances Heart Failure Risk Prediction

External news

Written by: Academic - advance access - HF
Rethinking Tricuspid Valve Regurgitation in Heart Failure - A Pathophysiology-based Holistic Approach for Individualized Patient Management
Written by: Academic - advance access - HF
Cardiac myosin-binding protein C in community-based patients with suspected heart failure
Written by: Academic - open access - HF
Cardiac myosin-binding protein C in community-based patients with suspected heart failure
Written by: Academic - advance access - HF
PCSK9 inhibition and cardiovascular outcomes by heart failure status: a pooled analysis of SPIRE-1 and SPIRE-2
Written by: Academic - advance access - HF
Cholesterol-lowering and heart failure
Written by: Academic - advance access - HF
Cardiac myosin-binding protein C, an incremental heart failure biomarker?
Written by: Academic - advance access - HF
Serum transthyretin as a staging biomarker in ATTR cardiomyopathy: promise, limitations, and the path forward
Written by: Academic - advance access - HF
Mapping the LVAD landscape: insights from the ITAMACS registry
Written by: Academic - advance access - HF
First Italian multicentre registry for Mechanically Assisted Circulatory Support (ITAMACS) report: 12-year experience of over 1000 durable LVAD patients
Written by: Academic - advance access - HF
Rethinking Myocarditis and Genetic Susceptibility in Severe Paediatric Cardiomyopathy